Background: Autologous free flap breast reconstruction (ABR) is a valuable surgical option for patients following mastectomy. The COVID-19 pandemic has led to a myriad of factors that have affected access to care, hospital logistics, and post-operative outcomes. This study aims to identify differences in patient selection, hospital course and severity, and post-operative outcomes for patients who underwent ABR during and prior to the COVID-19 pandemic.
Methods: Patients undergoing ABR from the ACS-NSQIP 2019-2020 database were analyzed to compare sociodemographics, hospital course, and outcomes over the first post-operative month. Multivariable logistic regression was used to identify factors predictive of complications based on operative year.
Results: 3,770 breast free flaps were stratified into two groups based on the timing of reconstruction (pre-pandemic and pandemic groups). Patients with a diagnosis of disseminated cancer were significantly less likely to undergo ABR during the COVID-19 pandemic. On univariate analysis, there were no significant differences in post-operative complications between the two groups. When controlling for potentially confounding sociodemographic and clinical risk factors, the COVID-19 group was significantly more likely to undergo reoperation compared to the pre-pandemic group (p< 0.05).
Conclusion: When comparing outcomes for patients who underwent ABR prior to and during the COVID-19 pandemic, we found a significant increase in the odds of reoperation for those who had ABR during the pandemic. Debridement procedures and exploration for postoperative hemorrhage, thrombosis or infection increased from the pre-pandemic group to the COVID-19 group. Notably, operative times decreased.